Investing.com - Grifols ADR reported on Monday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Grifols ADR announced earnings per share of €0.1134 on revenue of €1.54B. Analysts polled by Investing.com anticipated EPS of €0.3151 on revenue of €1.57B.
Grifols ADR shares are up 3.56% from the beginning of the year and are trading at €11.63 , down-from-52-week-high.They are outperforming the Nasdaq which is down 12.47% from the start of the year.
Grifols ADR follows other major Healthcare sector earnings this month
Grifols ADR's report follows an earnings matched by Roche Holding ADR on Thursday, February 3, 2022, who reported EPS of €1.29 on revenue of €17.54B, compared to forecasts EPS of €1.29 on revenue of €17.1B.
Pfizer had beat expectations on Tuesday, February 8, 2022 with fourth quarter EPS of €1.08 on revenue of €23.84B, compared to forecast for EPS of €0.8742 on revenue of €24.16B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar